Diagnostic Challenges and Management of Fibromyalgia.

Autor:	Qureshi AG; Medicine and Surgery, Jinggangshan Medical University, Jian, CHN., Jha SK; Internal Medicine, Kankai Hospital, Birtamode, NPL., Iskander J; Family Medicine, American University of Antigua, St. John's, ATG., Avanthika C; Medicine and Surgery, Karnataka Institute of Medical Sciences, Hubli, IND.; Pediatrics, Karnataka Institute of Medical Sciences, Hubli, IND., Jhaveri S; Medicine, Smt Nathiba Hargovandas Lakhmichand Municipal Medical College (NHLMMC), Ahmedabad, IND., Patel VH; Family Medicine, GMERS Medical College and Hospital, Valsad, IND.; Internal Medicine, Gujarat Cancer Society Medical College and Research Center, Ahmedabad, IND., Rasagna Potini B; Internal Medicine, Kamineni Institute of Medical Sciences, Hyderabad, IND., Talha Azam A; Internal Medicine, Allama Iqbal Medical College, Lahore, PAK.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2021 Oct 11; Vol. 13 (10), pp. e18692. Date of Electronic Publication: 2021 Oct 11 (Print Publication: 2021).
DOI:	10.7759/cureus.18692
Abstrakt:	The World Health Organization regards chronic pain to be a public health concern. In clinical medicine, fibromyalgia (FM) is the most prevalent chronic widespread pain disease. In terms of impairment, consumption of health and social resources, and impact on primary and speciality care systems, it has reached worrisome proportions. This disease is frequently managed by primary care providers. Because of its intricacy, fibromyalgia diagnosis and treatment can be difficult. Fibromyalgia is a controversial condition. It might appear ill-defined in comparison to other pain conditions, with no clear knowledge of pathophysiology and hence no particular targeted therapy. This invariably sparks debates and challenges. There is no obvious cut-off point that distinguishes FM from non-FM. The diagnosis of fibromyalgia has been complicated by several factors, including patients' health-seeking behaviour, symptom identification, and physician labelling of the disease. Fibromyalgia is currently considered a centralized pain condition, according to research that has improved our understanding of its etiopathology. A multidisciplinary strategy combining pharmacological and non-pharmacological therapies based on a biopsychosocial paradigm can result in effective therapy. Cultural and psychosocial variables appear to be a recent development in fibromyalgia, and they appear to have a larger influence on physician diagnosis than severe symptom levels in FM patients. Although physicians rely on FM criteria as the only way to classify FM patients in research and clinical settings, some crucial elements of the diagnostic challenge of fibromyalgia remain unsolved - invalidation, psychosocial variables, and diverse illness manifestation are some examples. Beyond the existing constructional scores, physicians' judgment gained in real communicative contexts with patients, appears to be the only dependable route for a more accurate diagnosis for fibromyalgia. We have performed an exhaustive review of the literature using the keywords "Fibromyalgia", "challenges" and "diagnosis" in PubMed and Google Scholar indexes up to September 2021. This article aims to examine the causes, diagnosis, and current treatment protocols of FM, as well as discuss some continuing debates and diagnostic challenges which physicians face in accurately diagnosing fibromyalgia. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2021, Qureshi et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu